The recall involves Veklury for Injection with Lot #47035CFA (NDC # 61958-2901-02) and an expiration date of November 2025. Gilead is voluntarily recalling 1 lot of Veklury ® (remdesivir) for ...
Gilead Sciences recently announced a voluntary recall of one lot of its Veklury (remdesivir) for injection 100 mg/vial, to the consumer level, after confirming the presence of a glass particle in the ...
The new "F4" formulation is 4 times more concentrated than the version currently available on the market. Theratechnologies announced that the Food and Drug Administration (FDA) has approved Egrifta ...
The following are 13 tips for safe and appropriate use of single-dose and multiple-dose vials for injected medication from The Joint Commission’s recent sentinel alert on the subject: 1. Discard any ...
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the availability in the United States of Ertapenem for Injection in a 1 gram vial presentation. The new product is the generic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback